Edward Kim
Medical Oncology · Charlotte, NCNPI 1972688984
Payments from drug & device makers
Across 264 payments — averaging $6286.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$815K
- Genentech, Inc.$212K
- AstraZeneca$208K
- Astrazeneca UK Limited$191K
- Incyte Corporation$41K
- Regeneron$35K
- plus $156K from 30 others
Across 11 payments — averaging $2066.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$6K
- Celltrion, Inc.$5K
- Bristol Myers Squibb$3K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- Genentech, Inc.$2K
- Novartis Pharma AG$2K
- plus $2K from 1 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 39 | $815,112 |
| Genentech, Inc. | 41 | $212,193 |
| AstraZeneca | 23 | $208,398 |
| Astrazeneca UK Limited | 9 | $191,269 |
| Incyte Corporation | 7 | $41,128 |
| Regeneron | 8 | $35,270 |
| Eli Lilly | 4 | $31,090 |
| Novartis | 3 | $22,952 |
| Boehringer Ingelheim | 13 | $20,347 |
| Genentech USA, Inc. | 9 | $13,838 |
| Boehringer Ingelheim International GmbH | 8 | $12,819 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 8 | $7,642 |
| Roche Molecular Systems, Inc. | 14 | $6,570 |
| F. Hoffmann-la Roche AG | 5 | $5,249 |
| Partner Therapeutics, Inc. | 9 | $5,002 |
| EMD Serono, Inc. | 1 | $4,550 |
| GSK | 3 | $4,065 |
| Pfizer | 4 | $3,841 |
| E.r. Squibb & Sons, L.L.C. | 5 | $3,600 |
| Sanofi | 5 | $2,928 |
| Gilead | 2 | $2,528 |
| Lilly USA, LLC | 7 | $2,128 |
| Roche Sequencing Solutions, Inc. | 1 | $1,500 |
| Array Biopharma Inc | 2 | $1,491 |
| Bayer | 4 | $1,242 |
| Exelixis Inc. | 1 | $660 |
| Celltrion, Inc. | 1 | $600 |
| Mirati Therapeutics, Inc. | 3 | $596 |
| Intuitive Surgical | 3 | $256 |
| Boston Scientific | 15 | $206 |
| Johnson & Johnson | 2 | $114 |
| Daiichi Sankyo Inc. | 1 | $108 |
| Amgen | 1 | $80 |
| Novocure Inc. | 1 | $47 |
| AbbVie | 1 | $47 |
| Masimo Corporation | 1 | $40 |
How this compares
$1,659,505 in reported general payments places this provider in the 85th percentile of 170 medical oncology providers in North Carolina.
Other medical oncology in Charlotte
- Antoinette TanCharlotte$14.9M
- Nilanjan GhoshCharlotte$6.3M
- Kathryn MilehamCharlotte$4.7M
- David RizzieriCharlotte$1.8M
- Jimmy HwangCharlotte$1.3M
- Kimberly StricklandCharlotte$1.1M
- Obiageli OgbataCharlotte$861K
- Daniel CarrizosaCharlotte$827K
- Mohamed SalemCharlotte$658K
- Ashley SumrallCharlotte$627K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.